You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sbrt

Showing 1 - 25 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Trial (SBRT, Cadonilimab)

Not yet recruiting
  • Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
  • (no location specified)
Feb 8, 2023

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Carcinoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Oct 6, 2023

Treatment Trial in Shanghai (ADT, SBRT)

Recruiting
  • Treatment
  • Shanghai, Shanghai, China
    Changhai hospital
Aug 9, 2022

Ovarian Cancer Recurrent Trial in Sutton, London (Niraparib oral capsule, SBRT)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Niraparib oral capsule
  • SBRT
  • Sutton, Surrey, United Kingdom
  • +1 more
Aug 10, 2023

NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Anlotinib Hydrochloride
  • +2 more
  • (no location specified)
Aug 2, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Feb 7, 2023

Treatment Trial in Shanghai (SBRT, Chemotherapy)

Recruiting
  • Treatment
  • Shanghai, Shanghai, China
    Changhai hospital
Jul 10, 2022

Breast Cancer Trial (SHR-1316 at a dose 20mg/kg q3w, SHR6390 at a dose of 150mg orally, daily, SBRT)

Recruiting
  • Breast Cancer
  • SHR-1316 at a dose 20mg/kg q3w
  • +2 more
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Sep 12, 2022

HCC Trial in Hong Kong (procedure, radiation, drug)

Active, not recruiting
  • HCC
  • TACE
  • +2 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Oct 24, 2022

Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

Active, not recruiting
Has Results
  • Metastatic Non-small Cell Lung Cancer
  • Metastatic Triple-negative Breast Cancer
  • ADV/HSV-tk
  • +3 more
  • Houston, Texas
    Houston Methodist Cancer Center
Dec 28, 2022

Sarcoma, Radiosurgery Trial in France (Atezolizumab, SBRT)

Recruiting
  • Sarcoma
  • Radiosurgery
  • Caen, France
  • +10 more
Jul 22, 2022

Stage III Non-small-cell Lung Cancer Trial in Providence (Durvalumab, SBRT)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Providence, Rhode Island
  • +1 more
Feb 23, 2022

Pancreatic Cancer Trial in Munich, Heidelberg, Zürich (SBRT, SOC chemo)

Recruiting
  • Pancreatic Cancer
  • SBRT
  • SOC chemotherapy
  • Munich, Bavaria, Germany
  • +2 more
Apr 6, 2022

NSCLC Trial in Wuhan (Camrelizumab, Apatinib, Docetaxel injection)

Recruiting
  • Non-Small Cell Lung Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 29, 2022

Radiotherapy, Immunotherapy, Liver Metastases Trial in Shanghai (SBRT, Chemotherapy, PD-1 antibody)

Recruiting
  • Radiotherapy
  • +3 more
  • SBRT
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 2, 2023

Hepatocellular Carcinoma Trial in Delhi (DEB, SBRT)

Recruiting
  • Hepatocellular Carcinoma
  • Delhi, NCT, India
    Medanta
Nov 19, 2021

Pancreatic Cancer Trial in United States (drug, radiation, procedure)

Active, not recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
  • +9 more
Sep 7, 2022

Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic

Terminated
Has Results
  • Histologically or Cytologically Confirmed Pancreatic Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2022

NSCLC Trial in Guangzhou (SBRT, Tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 17, 2022

Urothelial Carcinoma Trial in Ann Arbor (Pembrolizumab, SBRT)

Terminated
Has Results
  • Urothelial Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 13, 2021

Pancreatic Cancer Trial in Herlev (drug, radiation, biological)

Not yet recruiting
  • Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Feb 8, 2023

Carcinoma, Hepatocellular Trial in Navi Mumbai (radiation, procedure, drug)

Recruiting
  • Carcinoma, Hepatocellular
  • SBRT
  • +2 more
  • Navi Mumbai, Maharashtra, India
  • +1 more
Apr 25, 2022

Head and Neck Squamous Cell Carcinoma, Metastases, Immunotherapy Trial in Beijing (Sintilimab, SBRT, Platinum based chemo)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Beijing, China
    Cancer hospital, Chinese Academy of Medical Sciences
Nov 16, 2021

NSCLC Metastatic Trial in Shanghai (Almonertinib, SBRT)

Recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 23, 2023